EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT (CANADA)Exclusive License and Distribution Agreement • August 8th, 2024 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • New York
This Exclusive License and Distribution Agreement (Canada) (“Agreement”) is entered into on June 27, 2024 (the “Effective Date”) between Coherus BioSciences, Inc., a company organized and existing under the laws of the State of Delaware, having its main offices at 333 Twin Dolphin Drive, Suite 600 Redwood City, CA 94065 (“Coherus”) and Apotex, Inc., a company incorporated under the laws of Ontario, Canada, and having its registered address at 150 Signet Drive, Toronto, Ontario, Canada, including its Affiliates (“Apotex”). Coherus and Apotex may each be referred to herein as a “Party” or collectively as the “Parties.”
